Table 1. Clinical characterization of patients with ulcerative colitis in antibiotics and placebo groups.
Characteristics | Antibiotic group (n = 12) | Placebo group (n = 8) | p-value |
Mean age, year (range) | 39.75 (27–69) | 44.0 (18–62) | P>0.2 |
Gender (male/female) | 7/5 | 7/1 | P>0.2 |
Mean duration of disease, year (range) | 7.1 (1–20) | 6.4 (1–21) | P>0.2 |
Current activity (mild/moderate/severe) | 5/7/0 | 4/3/1 | P>0.2 |
Extent of disease, number of patients (%) | P>0.2 | ||
Pan colitis | 3 (25) | 2 (25) | |
Left-sided colitis | 6 (50) | 4 (50) | |
Proctitis | 3 (25) | 2 (25) | |
Concomitant medications during study | |||
Number of patients (%) | P>0.2 | ||
Sulfasalazine | 8 (66.7) | 5 (62.5) | |
5-ASA | 4 (33.3) | 3 (37.5) | |
Glucocorticoid | 3 (25.0) | 2 (25.0) |
5-ASA, mesalazine.